Aleafia Health (DB:ARAH) - Prezzo delle azioni, notizie e analisi

ARAH Panoramica delle azioni

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. Maggiori dettagli

ARAH analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	0/6
Dividendi	0/6

Analisi del rischio

Gli utili sono diminuiti del 30% all'anno negli ultimi 5 anni

Non ha una capitalizzazione di mercato significativa ( €8M )

Patrimonio netto negativo

Le azioni sono altamente illiquide

+ 1 più rischio

Aleafia Health Inc. Concorrenti

Biofrontera

XTRA:B8FK

€16.1m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.6m

Redx Pharma

DB:0RX

€65.0m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Aleafia Health
Prezzi storici delle azioni
Prezzo attuale dell'azione	CA$0.015
Massimo di 52 settimane	CA$0.079
Minimo di 52 settimane	CA$0.0005
Beta	1.73
1Variazione di 1 mese	0%
Variazione a 3 mesi	3,000.00%
Variazione di 1 anno	-50.79%
3Variazione a 3 anni	-94.60%
Variazione a 5 anni	-97.67%
Variazione dall'IPO	-96.70%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	ARAH	DE Pharmaceuticals	DE Mercato
7D	0%	1.6%	1.1%
1Y	-50.8%	-19.0%	7.2%

Ritorno vs Industria: ARAH ha avuto una performance inferiore rispetto al German Pharmaceuticals che ha registrato un rendimento -19 % nell'ultimo anno.

Rendimento vs Mercato: ARAH ha avuto una performance inferiore al mercato German che ha registrato un rendimento 7.2 % nell'ultimo anno.

Volatilità dei prezzi

Is ARAH's price volatile compared to industry and market?
ARAH volatility
ARAH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.0%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Prezzo delle azioni stabile: Il prezzo delle azioni di ARAH è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: Dati insufficienti per determinare la variazione della volatilità di ARAH nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
n/a	158	Tricia Symmes	www.aleafiahealth.com

Aleafia Health Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Aleafia Health con la sua capitalizzazione di mercato?
ARAH statistiche fondamentali
Capitalizzazione di mercato	€5.48m
Guadagni(TTM)	-€23.53m
Ricavi(TTM)	€29.13m

0.2x

Rapporto P/S

-0.2x

Rapporto P/E

ARAH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
ARAH Conto economico (TTM)
Ricavi	CA$42.85m
Costo del fatturato	CA$36.85m
Profitto lordo	CA$6.00m
Altre spese	CA$40.61m
Guadagni	-CA$34.61m

Ultimi guadagni dichiarati

Mar 31, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.086
Margine lordo	14.00%
Margine di profitto netto	-80.77%
Rapporto debito/patrimonio netto	-499.1%

Come si è comportato ARAH nel lungo periodo?

Vedi performance storica e confronto

ARAH Panoramica delle azioni

Analisi del rischio

Aleafia Health Inc. Concorrenti

XTRA:B8FK

€16.1m

DUSE:SBX

€27.9m

XTRA:HIGH

€57.6m

DB:0RX

€65.0m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Recent updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Now 33% undervalued

Aleafia Health Inc. Announces Board Changes

Now 36% undervalued after recent price drop

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

High number of new and inexperienced directors

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: €0.59

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

New 90-day high: €0.38

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share